Home › NDC Lookup › RxCUI directory › RxCUI 309290

Ciclopirox 7.7 MG/ML Topical Lotion — RxCUI 309290

RxNorm drug concept · Semantic clinical drug
RxCUI 309290 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI309290
Official nameCiclopirox 7.7 MG/ML Topical Lotion
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asciclopirox 0.77 % Topical Lotion; ciclopirox 0.77 % (ciclopirox olamine 1 % ) Topical Lotion
FDA products mapped5
Package NDCs mapped7
Reported Medicaid activity (SDUD)12,069 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ciclopirox Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Fungal nail infections are slow to clear, and Ciclodan nail lacquer is no exception. In clinical studies, treatment lasted up to 48 weeks. Only a small percentage of patients achie...
  • How long does it take for the nail lacquer to work?
  • No — that's actually one of the most important things to get right. You apply Ciclodan once a day and leave it on. Each new coat goes right on top of the previous one. After seven...
  • Do I need to remove the nail lacquer every night before I apply a new coat?
📖 Read our full Ciclopirox Topical guide →

🕸️ Concept Web — How Ciclopirox 7.7 MG/ML Topical Lotion Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ciclopirox 7.7 MG/ML Topical Lotion RxCUI 309290

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ciclopirox 21090
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Loprox 227285
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ciclopirox Topical Lotion 377874
    • Ciclopirox Topical Product 1163131
    • Ciclopirox Topical Lotion [Loprox] 365800
    • Loprox Topical Product 1180282
    • Topical Lotion 316983
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Ciclopirox 7.7 MG/ML 343172
    • Ciclopirox 7.7 MG/ML Topical Lotion [Loprox] 351383
    • Ciclopirox 7.7 MG/ML [Loprox] 575314

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ciclopirox 7.7 MG/ML SCDC · 343172
  • Ciclopirox Topical Lotion SCDF · 377874
  • Ciclopirox Topical Product SCDG · 1163131

Brand-Name Concepts

  • Ciclopirox 7.7 MG/ML Topical Lotion [Loprox] SBD · 351383
  • Ciclopirox 7.7 MG/ML [Loprox] SBDC · 575314
  • Ciclopirox Topical Lotion [Loprox] SBDF · 365800
  • Loprox Topical Product SBDG · 1180282
  • Loprox BN · 227285

📦 FDA Products & Package NDCs

5 products · 7 package NDCs
7 package NDCs map to RxCUI 309290 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
45802-0400-46 1 BOTTLE in 1 CARTON (45802-400-46) / 60 mL in 1 BOTTLE Ciclopirox Olamine Padagis Israel Pharmaceuticals Ltd 2006-12-29
45802-0400-49 1 BOTTLE in 1 CARTON (45802-400-49) / 30 mL in 1 BOTTLE Ciclopirox Olamine Padagis Israel Pharmaceuticals Ltd 2006-12-29
63629-2522-01 1 BOTTLE in 1 CARTON (63629-2522-1) / 30 mL in 1 BOTTLE Ciclopirox Olamine Bryant Ranch Prepack 2006-12-29
71335-2717-01 1 BOTTLE in 1 CARTON (71335-2717-1) / 60 mL in 1 BOTTLE Ciclopirox Olamine Bryant Ranch Prepack 2025-07-28
71335-2915-01 1 BOTTLE in 1 CARTON (71335-2915-1) / 30 mL in 1 BOTTLE Ciclopirox Olamine Bryant Ranch Prepack 2025-10-24
72162-1406-03 1 BOTTLE in 1 CARTON (72162-1406-3) / 30 mL in 1 BOTTLE Ciclopirox Olamine Bryant Ranch Prepack 2023-10-02
72162-1406-06 1 BOTTLE in 1 CARTON (72162-1406-6) / 60 mL in 1 BOTTLE Ciclopirox Olamine Bryant Ranch Prepack 2023-10-02
Observed labelers: Bryant Ranch Prepack (5) · Padagis Israel Pharmaceuticals Ltd (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.5902
Range $0.5852–$0.5953 · middle 50% $0.5877–$0.5928 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.